Skip to main content
. 2024 Dec 24;11:1500969. doi: 10.3389/fvets.2024.1500969

Figure 5.

Figure 5

MiR-145-targeted SOX9 to inhibit chondrogenic differentiation of RMCs. (A) Alisin blue staining of RMCs with different treatments. (B) Quantitative analysis of Alcian blue staining. (C) The expression of chondrogenic genes of RMCs with different treatments was analyzed using qRT-PCR. (D) The expression of chondrogenic proteins of RMCs with different treatments were analyzed using WB. (E) Quantitative analysis of WB.